Casey Eye Institute
Casey Eye Institute
Portland, Oregon, United States9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa, retinitis pigmentosa 4 | Recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT07408232 | |
| A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control | eye disorder, myopia, refractive error | Recruiting | Phase 3 | 2026-06-26 | NCT07095894 | |
| Promising ROd-cone DYstrophy Gene therapY | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-15 | NCT05748873 | |
| Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT06380517 | |
| Bevacizumab Treatment For Type 1 ROP | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, eye disorder, retinal disorder, retinopathy of prematurity | Active, not recruiting | Phase 2 | 2026-02-11 | NCT04634578 | |
| A Randomized Trial to Evaluate Sequential vs Simultaneous Patching | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT04378790 | |
| A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) | Eye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorder | Enrolling by invitation | Phase 2 | 2024-10-30 | NCT06275620 | |
| A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE) | Eye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorder | Active, not recruiting | Phase 2 | 2024-08-12 | NCT06333249 | |
| Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations | Eye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorder | Active, not recruiting | Phase 1 / Phase 2 | 2024-05-20 | NCT03316560 |